Basic Information
Basic information for ITGA9-AS1-232-41aa
Peptide Name ITGA9-AS1-232-41aa
Genome Position chr3:37749536-37749557,37753952-37754052[-]
Species Human
Peptide Sequence MIYLHFKKKSLRSKWTQPASHKLSGSLILFLEIRSQSFPEK
Peptide Length 41
Unique No (ITGA9-AS1-221-41aa,ITGA9-AS1-222-41aa,ITGA9-AS1-225-41aa,ITGA9-AS1-230-41aa,ITGA9-AS1-231-41aa)
Grand Average of Hydropathicity -0.4024
Relative Molecular Mass 5582.35
Experimental Evidences no
lncRNA ID/Name ENSG00000235257;ITGA9-AS1
Transcript ID/Name ENST00000663634;ITGA9-AS1-232
Transcript Length 1282
Coding Ability 0.5897
DNA Sequence Corresponding to Peptide ATGATCTATCTTCACTTCAAAAAGAAATCTCTAAGGAGCAAGTGGACACAGCCTGCCTCCCATAAGCTGTCTGGCTCACTCATTTTATTCCTGGAAATCAGAAGTCAATCATTTCCTGAGAAA
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :